Case of Anti-Small Ubiquitin-Like Modifier Activating Enzyme Antibody-Positive Dermatomyositis with Sarcoidosis.
作者信息
Sakano Kei, Takahashi Reiko, Fukuyama Kunitaro
机构信息
Department of Dermatology, Kansai Rosai Hospital, Hyogo, Japan.
出版信息
Ann Dermatol. 2023 May;35(Suppl 1):S161-S162. doi: 10.5021/ad.21.054.
Abstract
摘要
相似文献
1
Case of Anti-Small Ubiquitin-Like Modifier Activating Enzyme Antibody-Positive Dermatomyositis with Sarcoidosis.
Ann Dermatol. 2023 May;35(Suppl 1):S161-S162. doi: 10.5021/ad.21.054.
2
Two cases with autoantibodies to small ubiquitin-like modifier activating enzyme: A potential unique subset of dermatomyositis-associated interstitial lung disease.
Int J Rheum Dis. 2019 Aug;22(8):1582-1586. doi: 10.1111/1756-185X.13593. Epub 2019 May 2.
3
High incidence of cancer in anti-small ubiquitin-like modifier activating enzyme antibody-positive dermatomyositis.
Rheumatology (Oxford). 2015 Sep;54(9):1745-7. doi: 10.1093/rheumatology/kev247. Epub 2015 Jul 9.
4
Clinically amyopathic dermatomyositis with diffuse erosive erythema in a patient with anti-small ubiquitin-like modifier activating enzyme antibody.
Int J Dermatol. 2022 Oct;61(10):e389-e391. doi: 10.1111/ijd.16124. Epub 2022 Feb 2.
5
Juvenile dermatomyositis associated with autoantibodies to small ubiquitin-like modifier activating enzyme: a report of 4 cases from North India and a review of literature.
Immunol Res. 2023 Feb;71(1):112-120. doi: 10.1007/s12026-022-09334-4. Epub 2022 Oct 24.
6
Diffuse pruritic erythema as a clinical manifestation in anti-SAE antibody-associated dermatomyositis: a case report and literature review.
Clin Rheumatol. 2019 Aug;38(8):2189-2193. doi: 10.1007/s10067-019-04562-w. Epub 2019 Apr 27.
7
Antibodies to small ubiquitin-like modifier activating enzyme are associated with a diagnosis of dermatomyositis: results from an unselected cohort.
Immunol Res. 2018 Jun;66(3):431-436. doi: 10.1007/s12026-018-9006-7.
8
Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients.
Autoimmunity. 2013 Jun;46(4):279-84. doi: 10.3109/08916934.2012.755958. Epub 2013 Feb 8.
9
Recalcitrant ulcers associated with anti-small ubiquitin-like modifier activating enzyme-positive dermatomyositis treated with surgery followed by intravenous immunoglobulin.
Australas J Dermatol. 2018 Feb;59(1):e76-e78. doi: 10.1111/ajd.12659. Epub 2017 Jun 29.
10
Diffuse erythema with 'angel wings' sign in Japanese patients with anti-small ubiquitin-like modifier activating enzyme antibody-associated dermatomyositis.
Br J Dermatol. 2018 Dec;179(6):1414-1415. doi: 10.1111/bjd.17026. Epub 2018 Sep 21.
本文引用的文献
1
Key Players and Biomarkers of the Adaptive Immune System in the Pathogenesis of Sarcoidosis.
Int J Mol Sci. 2020 Oct 7;21(19):7398. doi: 10.3390/ijms21197398.
2
Diffuse erythema with 'angel wings' sign in Japanese patients with anti-small ubiquitin-like modifier activating enzyme antibody-associated dermatomyositis.
Br J Dermatol. 2018 Dec;179(6):1414-1415. doi: 10.1111/bjd.17026. Epub 2018 Sep 21.
3
A case of sarcoidosis with interstitial lung disease mimicking clinically amyopathic dermatomyositis and rapidly progressive interstitial lung disease.
Case Rep Rheumatol. 2014;2014:195617. doi: 10.1155/2014/195617. Epub 2014 Nov 9.
4
Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis.
Arthritis Rheum. 2007 Sep;56(9):3132-7. doi: 10.1002/art.22862.
5
Polymyositis and dermatomyositis.
Lancet. 2003 Sep 20;362(9388):971-82. doi: 10.1016/S0140-6736(03)14368-1.
Zotero 插件